OmniGene Bioproducts holds U.S. and foreign patents on proprietary Bacillus
and Streptomyces vector systems and patents covering Bacillus
strains deleted for four different extracellular proteases.
U.S.
6,830,893 |
Microorganisms
and assays for the identification of antibiotics (2004) |
U.S.
5,874,278 |
Protease
deletion (1999) |
U.S.
5,620,880 |
Protease deletion
(1997) |
U.S.
5,589,383 |
Protease deletion
(1996) |
U.S.
5,294,542 |
Residual protease-III
(1994) |
U.S.
5,017,477 |
Enhancing
DNA sequences derived from the sacQ gene (1991) |
U.S.
7,291,489 |
Microorganisms
and processes for enhanced production of pantothenate (2007; assigned
to BASF) |
U.S.
7,244,593 |
Microorganisms
and processes for enhanced production of pantothenate (2007; assigned
to BASF) |
U.S.
7,220,561 |
Processes for enhanced
production of pantothenate (2007; assigned to BASF) |
U.S.
7,091,000 |
Bacterial
strains which overproduce riboflavin and methods of use thereof
(2006; assigned to DSM Nutritional Products) |
U.S.
6,841,366 |
Biotin
biosynthesis in Bacillus subtilis (2005; assigned to DSM IP Assets,
B.V.) |
U.S.
6,737,256 |
Overcoming
DAPA aminotransferase bottlenecks in biotin vitamers biosynthesis
(2004; assigned to Roche Vitamin Products) |
U.S.
6,551,813 |
Nutrient
medium for bacterial strains which overproduce riboflavin (2003;
assigned to Roche Vitamins, Inc.) |
U.S.
6,303,377 |
Biotin biosynthesis
in Bacillus subtilis (2001; assigned to Roche Vitamins, Inc.) |
U.S.
6,057,136 |
Biotin biosynthesis
in Bacillus subtilis (2000; assigned to Roche Vitamins, Inc.) |
U.S.
5,925,538 |
Bacterial strains
which overproduce riboflavin (1999; assigned to Roche Vitamins,
Inc.) |
U.S.
5,837,528 |
Bacterial strains
which overproduce riboflavin (1998; assigned to Hoffmann La Roche,
Inc.) |
>> Click here to learn
more about our key publications.
<< Click here to return
to the Technology Overview.
|
|